Yanjun Niu | Physical Activity | Innovative Research Award

Published on by Global Academic Awards

Innovative Research Award

Yanjun Niu
Affiliation Shanghai University of Sport
Country China
Scopus ID 59424566000
Documents 7
Citations 12
h-index 3
Subject Area Physical Activity
Event Global Academic Awards

Yanjun Niu
Shanghai University of Sport

Yanjun Niu, affiliated with Shanghai University of Sport, has developed a growing scholarly profile within the field of physical activity research. The available publication record indexed in Scopus reflects contributions that support evidence-based understanding of physical activity and related health sciences.[1]

Abstract

Yanjun Niu’s scholarly activities focus on physical activity and related health outcomes. The available publication record demonstrates participation in peer-reviewed scientific research addressing exercise science, public health, and evidence-based physical activity interventions. Indexed publications and citation metrics indicate an emerging academic profile with measurable scientific engagement.[1]

Keywords

  • Physical Activity
  • Exercise Science
  • Sports Medicine
  • Public Health
  • Health Promotion
  • Innovative Research Award

Introduction

Research in physical activity plays an important role in understanding health promotion, disease prevention, and athletic performance. Academic investigations contribute to improved clinical recommendations, community interventions, and policy development. Researchers working in this discipline support the continuous advancement of evidence-based practices through scientific publication and collaborative research.[2]

Research Profile

Yanjun Niu is affiliated with Shanghai University of Sport in China. According to the Scopus database, the researcher has authored seven indexed publications with twelve citations and an h-index of three. These bibliometric indicators demonstrate active participation in scholarly communication and developing research visibility within the field of physical activity.[1]

Research Contributions

  • Research related to physical activity and health.
  • Evidence-based approaches supporting exercise science.
  • Contribution to peer-reviewed scientific literature.
  • Promotion of interdisciplinary health research.

Publications

The researcher’s Scopus profile lists peer-reviewed publications within physical activity and sports science. These works collectively contribute to scientific understanding of exercise, health promotion, and related biomedical research areas.[1] Example DOI format for scholarly publications:

Research Impact

Bibliometric indicators provide one measure of scholarly influence. The available Scopus metrics indicate ongoing research activity with documented publications, citations, and an established h-index. These measures complement peer-reviewed dissemination and institutional research participation.[1]

Award Suitability

Based on the available scholarly record, Yanjun Niu demonstrates characteristics commonly considered during evaluation for research recognition, including peer-reviewed publications, measurable citation impact, institutional affiliation, and continued engagement in physical activity research. Final award decisions typically depend upon independent assessment using established evaluation criteria and supporting documentation.

Conclusion

Yanjun Niu represents an emerging researcher within the field of physical activity. The available publication record, citation profile, and institutional affiliation illustrate active engagement in scholarly research. Continued publication, collaboration, and scientific dissemination are expected to further strengthen future research impact and academic recognition.

References

    1. Elsevier. (n.d.). Scopus author details: Yanjun Niu, Author ID 59424566000. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=59424566000
    2. World Health Organization. Physical Activity Guidelines.
      https://www.who.int/news-room/fact-sheets/detail/physical-activity

Victor Wallis | Public Health | Best Researcher Award

Published on by Global Academic Awards

Prof. Victor Wallis | Public Health | Best Researcher Award

Berklee College of Music | United States

Prof. Victor Wallis, from Berklee College of Music, Boston, United States, is a distinguished researcher specializing in social theory, political economy, and public health. His work critically examines capitalism, socialism, and policy formation, addressing contemporary societal challenges, including the impact of COVID-19 on governance and social structures. With 72 scholarly publications, including open-access articles such as Covid-19 in the History of Capitalism and The Impact of Censorship on COVID-19 Policy Formation in the United States, alongside book chapters in respected outlets like Monthly Review and Socialism and Democracy, Prof. Victor Wallis demonstrates a strong and diverse research portfolio. His scholarship has been cited 203 times across 163 documents, with an h-index of 8, reflecting significant influence and academic recognition. Collaborating with 14 co-authors, his contributions bridge rigorous academic inquiry and social critique, highlighting his relevance and impact in contemporary research, making him a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

  • Wallis, V. (2025). Covid-19 in the history of capitalism. Capitalism Nature Socialism.

  • Wallis, V. (n.d.). Limits to growth

  • Wallis, V. (n.d.). Katsiaficas, George

  • Wallis, V. (n.d.). Monthly Review

  • Wallis, V. (n.d.). Zeitlin, Maurice

  • Wallis, V. (n.d.). Socialism and Democracy

  • Wallis, V. (n.d.). The Impact of Censorship on COVID-19 Policy Formation in the United States

 

Jane Warland | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Jane Warland | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Jane Warland, University of Adelaide, Australia

Assoc. Prof. Dr. Jane Elizabeth Warland is a distinguished midwifery academic at the University of Adelaide Medical School, with a clinical title and extensive experience in both academic and clinical settings. With over three decades in maternal health, she has served in various hospitals and held prestigious academic positions across UniSA and Curtin University. Her work bridges clinical care and cutting-edge research, particularly in perinatal health and stillbirth prevention. Dr. Warland is widely respected for her leadership, teaching excellence, and impactful publications. She remains an influential voice in maternal and neonatal care. 🌿📚

Publication Profile

Orcid

Google scholar

🎓 Education

Dr. Warland holds a PhD in Medicine (Health Sciences) from the University of Adelaide (2007), which cemented her focus on maternal and fetal health research. She also earned a Graduate Certificate in Education (University Teaching) from UniSA in 2009, highlighting her commitment to academic excellence. Additionally, she became a Registered Midwife in 1989 at the Queen Victoria Hospital, South Australia (now WCH). These educational milestones laid a strong foundation for her blended career in research, teaching, and clinical practice. Her qualifications reflect a lifelong dedication to improving outcomes in maternity care and advancing midwifery education. 🎓📖

💼 Experience

Dr. Warland’s professional journey includes decades as a Registered Nurse and Midwife from 1988 to 2007, serving in prominent South Australian hospitals. Transitioning into academia in 2008, she has held roles from Lecturer to Associate Professor, teaching research, midwifery practice, and perinatal health. Notably, she was Joint Chair at Curtin University/King Edward Memorial Hospital (2021–2023). At UniSA, she coordinated multiple courses and mentored students in midwifery and health sciences. Her dual experience in hands-on clinical care and academic leadership has significantly shaped maternal health education and policy across Australia. 🏥📘

🏆 Awards & Honors

While specific award titles are not explicitly listed, Dr. Warland’s long-standing leadership positions, joint academic chair roles, and continued appointments at major Australian universities highlight her recognition as a leading expert in her field. Her impact in stillbirth research and health communication strategies for pregnant women has earned her respect in national and international maternal health circles. Through honors such as research supervision, course coordination, and invitations to collaborative roles, she has consistently demonstrated academic excellence and professional dedication in midwifery science. 🏅🌟

🔬 Research Focus

Dr. Warland’s research primarily centers on stillbirth prevention, perinatal mental health, pregnancy health messaging, maternal sleep positions, and fetal well-being. Her interdisciplinary approach explores how behavioral and environmental factors influence pregnancy outcomes. She has supervised research on health communication, anxiety reduction in pregnant women, and fetal health awareness. With expertise spanning both psychology and midwifery, she bridges research with real-world applications to improve prenatal care. Her scholarship contributes to national awareness campaigns and informs guidelines for safer pregnancies. 🧠👶📊

Publication Top Notes

📚 Maternal sleep during pregnancy and poor fetal outcomes: a scoping review – 228 citations, 2018 🔍🍼
📚 Help-seeking for mental health problems in young refugees – 208 citations, 2009 🧠🌍
📚 Bearing witness: midwives experiences of witnessing traumatic birth – 177 citations, 2013 🍼😔
📚 Leadership in learning and teaching in higher education – 137 citations, 2015 🎓👩‍🏫
📚 Seeing and holding a stillborn baby: Mothers’ feelings – 119 citations, 2013 💔🍼
📚 Evidence for nursing practice – 118 citations, 2005 📘🩺
📚 STARS cohort study on late stillbirth experiences – 107 citations, 2015 👩‍🍼🌐
📚 Parenting paradox: parenting after infant loss – 103 citations, 2011 👨‍👩‍👧‍👦💔
📚 Umbilical cord characteristics and adverse outcomes – 85 citations, 2020 🔬🧬
📚 A triple risk model for unexplained late stillbirth – 84 citations, 2014 ⚠️🍼
📚 Understanding stillbirth stigma – 79 citations, 2020 🗣️🧠
📚 Assertiveness training for midwifery students – 77 citations, 2014 🧑‍⚕️🗯️
📚 Untold stories of infant loss – 76 citations, 2013 🍼💬

 

Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Published on by Global Academic Awards

Dr. Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Dr. Kidanu Hurisa Chachu,Network of Networks of HIV Positives in Ethiopia (NEP+), Ethiopia

Dr. Kidanu Hurisa Chachu is a seasoned Senior Public Health Specialist with over 16 years of extensive experience in the field. With a PhD in Public Health and advanced degrees in the same discipline, he has demonstrated leadership in managing national programs in HIV, TB, immunization, and environmental health. Currently serving as the Program Director at NEP+, he oversees strategic implementation across 300+ health facilities, coordinating community-based HIV care and psychosocial support. Previously, he served as a Technical Officer at UNDP, where he strengthened health and environment programs at the national level. His core strengths include project coordination, M&E, stakeholder engagement, data management, and advocacy. Dr. Kidanu is multilingual, fluent in English, Afan Oromo, and Amharic. His career is marked by data-driven decision-making, community impact, and successful partnerships with international donors, such as the Global Fund, UNAIDS, and PEPFAR.

Publication Profile

Google Scholar

🎓 Education

Dr. Kidanu holds a Doctor of Philosophy in Public Health from the University of South Africa (UNISA), where he is finalizing his doctoral research. His academic journey began with a Bachelor of Science in Public Health from Haramaya University in Ethiopia, completed in 2008. Driven by a passion for community health, he further pursued his Master’s degree in General Public Health from Wollega University, graduating in 2016. Throughout his academic path, Dr. Kidanu has focused on strengthening health systems, improving disease surveillance, and addressing public health challenges in resource-limited settings. His studies emphasize a strong foundation in research, statistical analysis, and results-based management, all of which are evident in his professional approach. His academic background has been essential to his leadership roles and to his ability to drive impactful, evidence-based public health interventions.

💼 Experience

Dr. Kidanu currently leads NEP+ as Program Director, overseeing HIV response strategies across Ethiopia. He manages over 600 adherence supporters and leads national initiatives like Community-Led Monitoring (CLM), economic empowerment, and mother support groups. Prior to NEP+, he served as Technical Officer at UNDP (2021–2024), providing strategic and technical guidance on health and environment programs. There, he collaborated with the Ministry of Health and Environmental Protection Authority to improve project outcomes, mobilize resources, and manage donor-funded initiatives. His earlier experience spans clinical practice, research, and M&E roles that focused on HIV, TB, immunization, and environmental health. Dr. Kidanu’s hands-on experience in fieldwork, stakeholder engagement, and donor coordination reflects his dedication to delivering sustainable public health outcomes and system strengthening across Ethiopia.

🏅 Awards and Honors

While specific awards are not explicitly listed, Dr. Kidanu’s career achievements reflect recognition at both national and international levels. At NEP+, he led the successful scale-up of key initiatives including Community-Led Monitoring and economic empowerment programs for PLHIV, achievements often recognized by partner institutions and donors. His leadership has enhanced Ethiopia’s HIV treatment adherence and digital M&E systems. At UNDP, his work contributed to policy development and was praised for aligning with SDG targets and donor expectations, particularly in collaboration with the EU and MoH. His consistent success in grant writing, program reporting, and stakeholder coordination underscores a highly commendable career. His track record suggests recognition through internal promotions, project expansions, and trusted leadership in donor-funded programs, affirming his status as a key figure in Ethiopia’s public health sector.

🔬 Research Focus

Dr. Kidanu’s research focus centers on health systems strengthening, monitoring and evaluation (M&E), and community-led HIV interventions. His doctoral work at UNISA contributes to the evidence base for improving adherence support, stigma reduction, and access to treatment in Ethiopia. His academic and field research explore the intersections of public health, environmental factors, and chronic disease management. He emphasizes participatory approaches, particularly Community-Led Monitoring (CLM), to generate real-time data and inform policy. Additionally, he’s contributed to studies involving maternal and child health, digital health systems, and the socio-economic empowerment of PLHIV. His evidence-driven strategies are reflected in national programs that integrate research findings into scalable interventions. His work contributes to global dialogues on sustainable HIV responses and health equity in low-resource settings.

Publication Top Notes

📘 Prevalence and Factors Associated with Current Cigarette Smoking among Ethiopian University Students: A Systematic Review and Meta‐Analysis – Journal of Addiction – Cited by: 21 – Year: 2020 🔍🚬📊
📘 Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia – HIV Medicine – Cited by: 0 – Year: 2025 🧬📈👥
📘 Viral suppression among patients in HIV/AIDS care at healthcare facilities in Ethiopia: Same-day antiretroviral initiation – PLOS ONE – Cited by: 0 – Year: 2025 💊📉🏥
📘 Retention of patients in HIV/AIDS care at the healthcare facility level in Ethiopia: Same-day antiretroviral initiation status – Unspecified Journal – Cited by: 0 – Year: 2024 🏥🔄🧪
📘 Same-day antiretroviral therapy initiation and its association with viral suppression and retention in HIV care in Ethiopia – University of South Africa (Thesis) – Cited by: 0 – Year: 2024 🎓📚📉
📘 Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia – HIV Medicine (duplicate) – Cited by: 0 – Year: 2025 🔁📊🧬

Sylvia Kusemererwa | Public Health | Best Researcher Award

Published on by Global Academic Awards

Dr. Sylvia Kusemererwa | Public Health | Best Researcher Award

Dr. Sylvia Kusemererwa, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Uganda

Dr. Sylvia Kusemererwa is a distinguished Scientist A, Project Leader, and Principal Investigator at MRC/UVRI & LSHTM Uganda Research Unit. She holds an MBChB and MPH from Makerere University and has extensive experience in clinical research, epidemiology, and infectious disease management. Dr. Kusemererwa has led multiple clinical trials on HIV prevention, malaria vaccines, and COVID-19 research. She actively contributes to national health policies, serving as Chair of the Masaka Regional Referral Hospital Research Ethics Committee. Her work has significantly impacted public health in Uganda and beyond. 📍

Publication Profile

Orcid

🎓 Education

Dr. Kusemererwa earned her MBChB (2001) and MPH (2010) from Makerere University, equipping her with expertise in public health and clinical research. She pursued specialized training in project management (PRINCE2), global health leadership (Afya Bora Fellowship), and research ethics. She has completed advanced courses in statistics, epidemiology, and scientific manuscript writing. Her certifications include GCP from LSHTM and Citiprogram HSP. Her continuous learning reflects her dedication to high-quality clinical trials and ethical research governance. 📚

👩‍⚕️ Experience

Dr. Kusemererwa has held key positions, including Scientist A at MRC Uganda, Clinical Coordinator at TASO Mbale, and Medical Officer at Kampala Medical Chambers. She has been a Principal Investigator and Study Coordinator for numerous trials on HIV vaccines, COVID-19, and malaria. Her leadership in clinical research spans over two decades, significantly advancing Uganda’s infectious disease research landscape. She also mentors researchers and chairs ethics committees, ensuring adherence to international research standards. 🏥

🏆 Awards & Honors

Dr. Kusemererwa has been recognized for her contributions to public health and research ethics. She is Chair of the Masaka Regional Referral Hospital Research Ethics Committee and a mentor in the MRC-CTU Mentorship Scheme. She has received fellowships in global health leadership and numerous accolades for her role in advancing vaccine research and ethical clinical trials in Uganda. Her commitment to scientific excellence has established her as a leader in biomedical research. 🌍

🔬 Research Focus

Dr. Kusemererwa specializes in clinical trials for infectious diseases, focusing on HIV prevention, malaria vaccines, and emerging infections like COVID-19. She has led Phase 2 and 3 trials on HIV PrEP, vaccine efficacy, and maternal immunization. Her research emphasizes public health impact, implementation science, and ethical considerations in clinical studies. She collaborates globally to optimize vaccine deployment and improve healthcare interventions in sub-Saharan Africa. 🧪

Publication Top Notes

  • “Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda” (2021)

    pmc.ncbi.nlm.nih.gov

  • “Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda” (2022)

    journals.plos.org

  • “Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis” (2024)

    bmjopen.bmj.com

  • “Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda” (2023)

  • “Contraceptive Preference Among Women at Risk of HIV Acquisition in Southwestern Uganda” (2018)

 

 

Serhat Aras | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

 

Publication Profile

Google Scholar


Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

 

Publication Top Notes  

  • Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
  • Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
  • The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
  • Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
  • Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
  • A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
  • Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
  • The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
  • Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

 

 

 

 

 

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Published on by Global Academic Awards

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

 

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

 

Publication Top Notes

  • Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
  • Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
  • Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
  • Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
  • Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
  • Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
  • Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
  • Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
  • Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
  • Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)